证券记录 · 已归档季度
ZBH
Zimmer Biomet Holdings, Inc. · Healthcare · Medical - Devices
25被追踪持有人
+3Δ持有人
107.43M持有股份
$10.58B报告持仓市值
+3新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +13.6% ·
股份流向 +1.9% ·
净新建仓位 +8.0%
· 公式
广泛增持：持股数量上升，持有人数量增加
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 91.62K | $4.55M | n/a | −2 |
| Q2 2026 | 156 | +1 | 159.53M | $13.74B | +8 | −8 |
| Q1 2026 | 159 | -2 | 157.26M | $14.21B | +8 | −11 |
| Q4 2025 | 160 | -1 | 174.74M | $15.72B | +3 | −3 |
| Q3 2025 | 25 | +3 | 107.43M | $10.58B | +3 | −1 |
| Q2 2025 | 20 | -3 | 103.64M | $9.45B | +2 | −5 |
| Q1 2025 | 20 | +3 | 59.00M | $6.68B | +3 | n/a |
| Q4 2024 | 17 | 0 | 58.85M | $6.22B | +1 | −1 |
| Q3 2024 | 16 | -2 | 46.04M | $4.97B | n/a | −2 |
| Q2 2024 | 18 | n/a | 44.34M | $4.81B | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 23.29M | +0.2% | $2.29B | 0.0% | ▲ Add | 2 | SEC ↗ ×6 |
| 2 | Dodge & Cox ✦ | 23.22M | +5.1% | $2.29B | 1.2% | ▲ Add | 6 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 16.15M | +0.2% | $1.59B | 0.0% | ▲ Add | 2 | SEC ↗ ×21 |
| 4 | T. Rowe Price ✦ | 15.08M | +1.9% | $1.49B | 0.2% | ▲ Add | 6 | SEC ↗ ×2 |
| 5 | State Street Global Advisors ✦ (被动) | 8.63M | -1.3% | $852.26M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | Geode Capital Management ✦ (被动) | 5.20M | +1.4% | $509.87M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Harris Associates (Oakmark) ✦ | 4.75M | +27.3% | $467.93M | 0.8% | ▲ Add | 2 | SEC ↗ ×2 |
| 8 | PRIMECAP Management ✦ | 4.25M | -9.8% | $418.69M | 0.3% | ▼ Trim | 6 | SEC ↗ |
| 9 | JPMorgan Chase ✦ | 1.78M | n/a | $175.20M | 0.0% | n/c | 1 | SEC ↗ ×34 |
| 10 | Morgan Stanley ✦ | 1.69M | n/a | $166.79M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 11 | AQR Capital Management ✦ | 929.90K | -28.5% | $91.60M | 0.1% | ▼ Trim | 6 | SEC ↗ ×5 |
| 12 | Goldman Sachs Group ✦ | 818.94K | n/a | $80.67M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 13 | Arrowstreet Capital ✦ | 473.61K | -8.0% | $46.65M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 14 | Marshall Wace ✦ | 301.97K | +21.0% | $29.74M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 15 | GAMCO Investors ✦ | 239.84K | -2.5% | $23.62M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 16 | Fidelity (FMR) ✦ | 143.03K | +18.8% | $14.09M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 17 | Millennium Management ✦ | 137.05K | +1031.8% | $13.50M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 121.80K | 新增 | $12.00M | 0.0% | New | 1 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 116.15K | 新增 | $11.44M | 0.0% | New | 1 | SEC ↗ ×2 |
| 20 | Wellington Management ✦ | 40.23K | +6.0% | $3.96M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 21 | Gotham Asset Management ✦ | 39.38K | -55.7% | $3.88M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 22 | Bridgewater Associates ✦ | 12.55K | +91.3% | $1.24M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 23 | Capital World Investors ✦ | 4.98K | +61.4% | $490,235 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | Fisher Asset Management ✦ | 4.39K | -2.1% | $433,003 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 25 | Two Sigma Investments ✦ | 3.39K | 新增 | $334,211 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Renaissance Technologies | $12.00M | 0.0% |
| Citadel Advisors | $11.44M | 0.0% |
| Two Sigma Investments | $334,211 | 0.0% |
已清仓
| Norges Bank | $225.87M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 908 持有人, 191.49M 股份, $15.84B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 11
Thornal Kevin R
Officer · 5.69K 股 · $528,978
Sep 04
Phipps Chad F
Officer · 3.00K 股 · $295,050
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 13
SC 13G/A: DODGE & COX
Aug 12
SC 13G: Capital International Investors
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据